Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer

Sex: Female

Ages: 18 Years – N/A

Phase: NA

Enrollment: 186

Sponsor: Erica Alves Nogueira Fabro

Summary

Double-blind Superiority Randomized Controlled Clinical Trial. Objective of the study: To evaluate the effectiveness of photobiomodulation using the LED board in the prevention of peripheral neuropathy in the lower limbs in women with breast cancer undergoing chemotherapy at the Cancer Hospital III of the National Cancer Institute (HCIII/INCA).

Eligibility Criteria

Inclusion Criteria:Women aged over 18 years, with breast cancer in stages I to IIIC and who have an indication for curative treatment with neoadjuvant or adjuvant chemotherapy in HCIII/INCA.Exclusion Criteria:Patients with a previous diagnosis of another primary cancerPatients undergoing surgery and/or chemotherapy at another InstitutionPatients who previously had altered sensitivity in the feetPatients who are unable to respond to questionnairesPatients unable to receive photobiomodulation due to acute lower limb infections

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05663723). StuddyBuddy aggregates publicly available trial information.